RobertHardiMD

Gastroenterology • Bethesda, MD

Advanced Endoscopic Interventional, Inflammatory Bowel Disease

Clinical Associate Professor, Medicine,George Washington University Medical School Senior Clinical Scientist, Medipredict, Hungary Medical Director, Altimmune, Gaithersburg, MD, USA

Join to view full profile

Dr. Hardi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hardi's full profile

Already have an account?

Office
5530 Wisconsin Ave Suite 645
Chevy Chase MD
Bethesda, MD 20815

Summary

Dr. Robert Hardi is a gastroenterologist in Bethesda, MD. He received his medical degree from Semmelweis University, trained in Hungary, Germany and the US and has been in private practice since 1984.He has special expertise in Inflammatory Bowel Diseases and colon cancer screening. He has participated extensively in clinical research in these areas as well as in most of GI.

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Gastroenterology, 1982 - 1984
University of New Mexico School of MedicineFellowship, Hematology and Medical Oncology, 1979 - 1981
Semmelweis UniversityClass of 1972

Certifications & Licensure

MD State Medical License 1984 - 2026
DC State Medical License 1984 - 2024
NM State Medical License 1980 - 1988
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

Fellow (AGAF) American Gastroenterological Association, 2010

Clinical Trials

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females Start of enrollment: 2007 Oct 01
Unknown status
Phase 2, Phase 3
A Four Arm Study to Evaluate the Safety and Efficacy of 3 Different Doses of RVX-100 Versus Placebo in Subjects With Irritable Bowel Syndrome Accompanied by Diarrhea (IBS-D) Start of enrollment: 2010 Mar 01
Suspended
Phase 2
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis Start of enrollment: 2012 Feb 01
Completed
Phase 2
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease Start of enrollment: 2013 Mar 01
Completed
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC) Start of enrollment: 2013 Aug 01
Completed
Phase 3
Monitoring Disease Activity Using Video Capsule Endoscopy (VCE) in Crohn's Disease (CD) Subjects Start of enrollment: 2013 Aug 01
Completed
Not Applicable
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease Start of enrollment: 2013 Sep 01
Completed
Phase 3
12-Week Study of Plecanatide for CIC (The CIC3 Study) Start of enrollment: 2013 Nov 01
Completed
Phase 3
Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori Start of enrollment: 2014 Jan 01
Completed
Phase 3
Microbiome Test for the Detection of Colorectal Polyps and Cancer Start of enrollment: 2014 Mar 01
Completed
SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI) Start of enrollment: 2015 May 01
Completed
Phase 2
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers Start of enrollment: 2014 Oct 01
Terminated
Open Label Efficacy and Safety of Anti-MAP (Mycobacterium Avium Ssp. Paratuberculosis) Therapy in Adult Crohn's Disease Start of enrollment: 2017 Mar 18
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

83 citations
Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis
Ronald Pruitt, John S. Hanson, Michael Safdi, Lawrence Wruble, Robert Hardi
The American Journal of Gastroenterology. 2002-12-01
114 citations
Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study
Lloyd Mayer, William J. Sandborn, Yuriy Stepanov, Karel Geboes, Robert Hardi
Gut. 2014-03-01
65 citations
Novel 1 L polyethylene glycol-based bowel preparation NER1006 for overall and right-sided colon cleansing: a randomized controlled phase 3 trial versus trisulfate.
Michael DeMicco, Lucy Clayton, Jeff Pilot, Michael S. Epstein, Pradeep Bekal
Gastrointestinal Endoscopy. 2017-08-10

Press Mentions

With New Partners, Johnson & Johnson Is Expanding Project to Predict Who Will Develop Certain Diseases, Find Ways to Prevent ThemMarch 22nd, 2016

Professional Memberships